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Background: Dyslipidemia is a risk factor of signiﬁcant coronary artery disease
(CAD). Coronary artery spasm (CAS) is also known to be a major cause of myocardial
ischemia. However, whether dyslipidemia adds any long-term clinical risk in CAS
patients (pts) is largely unknown. We evaluated the impact of dyslipidemia on 3-year
clinical outcomes in pts with signiﬁcant CAS.
Methods: A total of 2,797 consecutive pts without signiﬁcant CAD who underwent
acetylcholine (Ach) provocation test were enrolled between Nov 2004 and Oct 2010.
Pts were divided into two groups according to existence of dyslipidemia (Dyslipi-
demia group: n¼241, Normal group: n¼1368) and major clinical outcomes were
compared between the two groups up to 3 years.
Results: At baseline, pts with dyslipidemia had a higher incidence of elderly, hy-
pertension, diabetes and ﬁxed coronary lesion than pts without dyslipidemia. During
Ach provocation test, there was no difference in angiographic and clinical parameters
between the two groups. At 3 years, the dyslipidemia group had higher incidence of
recurrent chest pain (9.9% vs. 5.7%, p¼0.012) and major adverse cardiac & cere-
brovascular events (MACCE) including all-cause mortality, myocardial infarction,
coronary revascularization and cerebrovascular accidents (2.0% vs. 0.5%, p¼0.023).
However, after multivariate analysis, the only remaining difference was in recurrent
chest pain before (HR; 1.82, 95%C.I; 1.11-2.98, p¼0.016) and after propensity score
matching analysis (HR; 2.86, 95%C.I; 1.29-6.30, p¼0.009).
Conclusion: In this study, pts with dyslipidemia showed signiﬁcant association with
higher recurrent chest pain up to 3 years clinical follow up, suggesting higher chance
of profound endothelial dysfunction requiring intensive anti-anginal management and
close clinical follow up.P
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One-year Predictive Factors of Mortality in Diabetic Patients Presenting with
Acute Myocardial Infarction in the Tunisian Context
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Background: Diabetes mellitus is a major coronary risk factor in the emerging
countries with a deep impact on early and long-term prognosis. We sought to study
predictive factors of 1-year mortality in diabetic patients presenting with acute
myocardial infarction (AMI).
Methods: We retrospectively studied data from our monocentric AMI registry
including 1386 consecutive patients. Patients were enrolled between january 1998 and
january 2012. All patients were managed either by thrombolysis, primary percutaneous
coronary intervention or medical treatment. Diabetic patients were ﬁrst compared to
non diabetics regarding demographic and prognostic features then one-year predictive
factors of mortality in diabetics were studied in univariate and multivariate analysis.
Results: Out of the overall population, 487 (35.1%) patients were diabetics. Reper-
fusion therapies implemented were comparable between diabetics and non diabetics.
Compared to non diabetics, diabetic patients were more frequently female (26.3% vs.
13%, p<0.0001), suffered more frequently heart failure during hospital stay (24.2%
vs. 15.9%, p<0.0001) and had a higher 1-year mortality rate (12.7% vs. 7%,
<0.0001). In univariate analysis, factors signiﬁcantly related to 1-year mortality in
diabetic patients were female gender (39.3% vs. 24.3%, p¼0.013), an age >75 (17.7%
vs. 9.4%, p¼0.045), heart failure on admission (51.6% vs. 20%, p<0.0001), renalJACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/POSTEfailure on admission (35.5% vs. 8.5%, p<0.0001) and glycaemia higher than 15
mmol/L on admission (63.8% vs.43.2%, p¼0.003). In multivariate analysis, factors
independently associated with 1-year mortality were heart failure on admission (HR:
3.4, 95% CI: 1.8-6.3, p<0.0001), renal failure on admission (HR: 4, 95% CI: 2-8.1,
p<0.0001) and a glycaemia higher than 15 mmol/L on admission (HR: 2.2, 95% CI:
1.2-4.1, p¼0.009).
Conclusion: In diabetic patients presenting with AMI, heart failure, renal failure and a
glycaemia higher than 15 mmol/L on admission are independent predictive factors of
1-year mortality.
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The Clinical Signiﬁcance of Microalbuminuria in Patients with Chronic Kidney
Disease who Received Drug-Eluting Stents
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Background: The clinical signiﬁcance of microalbuminuria in CKD patients who
underwent drug-eluting stent implantation is unknown. Its signiﬁcance was examined
in this study.
Methods: Subjects were 145 elective CKD patients with 235 lesions, who received a
drug eluting stent, and were measured for urine albumin/creatinine ratio (UACR) on
the day after PCI. 120 patients,189 lesions, with UACR<30mg/g were classiﬁed the N
group and the 20 patients, 38 lesions, with 30 mg/g&UACR＜300 mg/g were classiﬁed
the M group. Late cardiac and cerebrovascular event-free survival (average follow-up
32.813.9 months) were studied.
Results: There was no signiﬁcant difference between the two groups in DM. There
was also no signiﬁcant difference revealed between the two groups for late loss (N
group 0.320.68mm, M group 0.270.65mm). Late adverse cardiac and cerebro-
vascular events were 1 cardiac death, 1 AMI, 1 heart failures requiring hospitalization,
9 cases of TLR in the N group and 1 AMI, 1 heart failures requiring hospitalization, 1
TLR, and 2 stroke in the M group, the M group had a signiﬁcantly higher rate of
stroke (p<0.05) and a tendency for lower freedom from late cardiac and cerebro-
vascular events (N group 91.7%, M group 80.0％; p¼0.1035).
Conclusion: It was suggested that the presence or absence of microalbuminuria in
CKD patients who received drug-eluting stents could be useful in predicting the
occurrence of late cardiac and cerebrovascular events.
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Background: Renal function usually evaluated by detecting the serum creatinine level
is an signiﬁcant prognostic factor in patients with coronary heart disease, however, a
normal range of serum creatinine can mask the established renal insufﬁciency.
Therefore, patients with normal serum creatinine level and reduced estimated
glomerular ﬁltration rate (eGFR) are likely to be ignored before coronary revascu-
larization, similarly, the prognosis of these group is easily neglected and still
indeterminate.
Methods: A total of 6,005 consecutive patients with coronary artery disease received
the coronary revascularization were prospectively recorded in this single-center reg-
istry study at Beijing Anzhen Hospital between July 2003 and June 2005. In present
study, 5173 consecutive patients with normal serum creatinine were selected grouped
by eGFR to follow up to analyzed prognosis after coronary revascularization. The
serum creatinine 1.2 mg/dl was deﬁned normal. eGFR (ml/min/1.73m2) is divided
into 3 stages (◎90, 60w89, <60). We compared the groups in respect of the primary
outcome of all-cause death, and the secondary outcome of main adverse cardiac and
cerebral vascular events (MACCE) d cardiac death, non-cardiac death, nonfatal
myocardial infarction (MI), nonfatal stroke and repeat revascularization, at a median
follow-up of 549 days.
Results: The mean serum creatinine was 0.97O0.32 [0.2, 6.5] mg/dl, with 5256
(87.5%) within normal limits. Among them, 5173 were suitable for our study; in 2265
(43.8%) eGFR was ◎90 ml/min/1.73m2, 2713 (52.4%) was 60w89 ml/min/1.73m2, 195
(3.8%) was 30w59 ml/min/1.73m2, and none (0%) was <30 ml/min/1.73m2.
During hospitalization, there were signiﬁcant differences in in-hospital all-cause
mortality (p¼0.006) and no differences in MACCE (p¼0.320) among the groups
distinguished by eGFR. During follow-up, there were still signiﬁcant differences in
follow-up all-cause mortality (p¼0.002) and no differences in MACCE (p¼0.240).
On Cox regression analysis, the independent risk factors for all-cause death after
coronary revascularization were age, body mass index (BMI), left ventricular ejection
fraction (LVEF), history of diabetes mellitus, indication for revascularization, number
of diseased cononary artery and failed revascularization; While, only LVEF, number
of diseased cononary artery and failed revascularization for MACCE.
Conclusion: Patients with normal serum creatinine and reduced eGFR is common in
patients receiving coronary revascularization, and in the present study, normal serum
creatinine with mild or moderate renal insufﬁciency is associated with adverse clinical
outcomes. In each group, the gender and mode of revascularization might lead to
signiﬁcant differences in prognosis. Therefore, it is essential to estimate the eGFR of
patients even if their serum creatinine is within normal limits.R/High Risk Patients: Diabetes, Heart Failure, Renal Failure, Others S53
